Lifeclean Q1’23: First take – PFAS dominates sales - Redeye

Redeye saw sales that were in line with our expectations. Sales continue to recover, driven by PFAS, which represented 54% of sales in the quarter. The patented Lifeclean products grew by 90% in the quarter. We will likely makes some small positive revisions to our estimates.

Länk till analysen i sin helhet: https://www.redeye.se/research/903136/lifeclean-q123-first-take-pfas-dominates-sales?utm_source=finwire&utm_medium=RSS